AstraZeneca Pharma India NSE
3345.45 00.00 (1.04%) 
To view real-time data of AstraZeneca Pharma India and trade with industry first features, Login or Open Free Demat Account.
Financials:
Income Statement
as of March 2022
| Financial Year | FY - |
| All Expenditure (Cr) | 0.00 |
| Operating Profit (Cr) | 0.00 |
| EBIDTA (Cr) | 0.00 |
| Profit Before Tax (Cr) | 0.00 |
| Tax (Cr) | 0.00 |
| Net Income (Cr) | 0.00 |
| EPS (Cr) | 0.00 |
| DPS (Cr) | 0.00 |
Balance Sheet
as of March 2022
Equities & Liabilities
| Financial Year | FY - |
| Share Capital (Cr) | 0.00 |
| Reserves & Surplus (Cr) | 0.00 |
| Current Liabiltiies (Cr) | 0.00 |
| Other Liabilities (Cr) | 0.00 |
| Total Liabilities (Cr) | 0.00 |
Assets
| Financial Year | FY - |
| Fixed Assets | - |
| Current Assets | - |
| Other Assets | - |
| Total Assets | - |
Cash Flows
as of March 2022
AstraZeneca Pharma India Financial Statements Overview
AstraZeneca Pharma India financial statements offers an overview of the company's Revenue, Income Statement, Balance Statement, Cash Flows and more. It helps to analyse the company's financial position and its revenue to profit trend. AstraZeneca Pharma India reported a Net Income of Rs. 0.00 and an Operating Profit of Rs. 0.00 in the . The Total Liabilities stood at Rs. 0.00 in the last year. The Earning Per Share (EPS) and Dividend Per Share (DPS) stood at Rs. 0.00 and Rs. 0.00 respectively. While, analysing Financial Statements of a company is crucial, it is equally important to look at the Share Price, Stock Performance, Fundamental Analysis, Technicals and Similar Stocks Comparision. It gives a sense of whether the company is growing, stable or deteriorating.
